Marc Adams

Marc Adams

Company: Dicerna Pharmaceuticals

Job title: Executive Director of Pharmacology


A native of Philadelphia with a PhD in Biochemistry, I have been working in biopharma discovery and early development for almost 25 years. During a long tenure as a biologist and research leader at Merck and Co., I began in small molecule oncology discovery, then entered the early but rapidly progressing area of nucleic acid therapeutics at a time filled with excitement and uncertainty. For the past 6 years I have served as Executive Director, Pharmacology at Dicerna Pharmaceuticals. In this role, I have helped to build and lead a team focused on discovery, technology development and translation of advanced RNAi technologies for unmet medical needs in viral hepatitis, chronic liver and cardiovascular disease, and oncology. At Dicerna, we are expanding the scope of RNAi through rigorous science and have forged alliances with five large pharmaceutical companies to accelerate our experimental medicines. We are soon going to witness the golden age of nucleic acid therapeutics and make a big difference in patients’ lives!


Chair’s Opening Remarks 8:50 am

Read more

day: Day Two

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.